Osteosarcoma
18 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
Osteosarcoma| Treatment and condition | Where it stands | Trials |
|---|
| Abemaciclib + Irinotecan + Temozolomide for sarcoma, ewing | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Archive Sample Retrieval + Biospecimen Collection + pH Low Insertion Peptide-exatecan Conjugate CBX-12 + Radiologic Imaging Procedure for sarcoma, ewing | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Biopsy for osteosarcoma | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Brachytherapy for osteosarcoma | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS) for sarcoma, ewing | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| DOCETAXEL + Hydroxychloroquine + Gemcitabine for osteosarcoma | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Durvalumab + oleclumab for osteosarcoma | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Echocardiography + Biospecimen Collection + Computed Tomography + Multigated Acquisition Scan + Zanzalintinib for sarcoma, ewing | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| HS-20093 for osteosarcoma | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Irinotecan + Temozolomide for sarcoma, ewing | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Naxitamab for sarcoma, ewing | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Peptide vaccine IPX for sarcoma, ewing | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Proton beam radiation therapy + Surgical resection for osteosarcoma | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Proton beam radiation therapy + Surgical resection + PAZOPANIB + Doxorubicin + Ifosfamide for osteosarcoma | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Proton beam radiation therapy + Surgical resection + SELINEXOR + PAZOPANIB + Doxorubicin + Ifosfamide for osteosarcoma | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Regorafenib for osteosarcoma | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Trametinib + Doxorubicin + CISPLATIN + Gefitinib + Disulfiram + SUNITINIB + Methotrexate for osteosarcoma | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Trametinib + Gefitinib + Disulfiram + Ifosfamide + SUNITINIB for osteosarcoma | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|